OutSee

AI and genomics
#Artificial intelligence (AI) #Funding #Genomics #Innovate UK #OutSee

OutSee receives Innovate UK grant for agentic AI pilot study

Genomics drug discovery company OutSee has been awarded funding through Innovate UK’s Investor Partnership Grant, jointly provided by Innovate UK and Empirical Ventures.   The grant will enable OutSee to conduct a pilot study for a prototype target validation sub-system, designed for initial triage of potential drug targets… Read More

#News

Genomics
#ALS #Genomics #Longitude Prize #OutSee

OutSee receives Discovery Award from Longitude Prize on ALS 

OutSee has received a Discovery Award from the Longitude Prize on ALS, the genomics and drug discovery company has announced.  The award will grant OutSee access to genomic data from 9,000 amyotrophic lateral sclerosis (ALS) patients, in addition to £100,000 ($134,000) in funding, supporting a research project… Read More

#News

#Drug discovery #Genomics #OutSee

OutSee raises £2.5m and partners with o2h discovery 

Genomic and drug discovery company OutSee has closed a £2.5 million ($3.4 million) seed funding round and partnered with contract research organisation o2h discovery to develop a lead drug target candidate.  The partnership aims to launch a collaborative drug discovery programme for OutSee’s lead target candidate, identified through the company’s genomic target discovery and precision medicine… Read More

#Business & Investment #News

Seed fund
#Artificial intelligence (AI) #Drug discovery #Genetics / genomics #OutSee #Seed funding #Start-ups

Predictive genomics pioneer OutSee raises £1.8m

OutSee has secured £1.8 ($2.4) million in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.   The funds will support OutSee through the next phase of its growth strategy, with a focus on expanding the company’s in-house target discovery programme… Read More

#Business & Investment #News #Start-up Zone